These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 14612929

  • 1. Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements.
    Kondoh N, Hada A, Ryo A, Shuda M, Arai M, Matsubara O, Kimura F, Wakatsuki T, Yamamoto M.
    Int J Oncol; 2003 Dec; 23(6):1575-83. PubMed ID: 14612929
    [Abstract] [Full Text] [Related]

  • 2. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
    Liedtke C, Zschemisch NH, Cohrs A, Roskams T, Borlak J, Manns MP, Trautwein C.
    Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
    [Abstract] [Full Text] [Related]

  • 3. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI.
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [Abstract] [Full Text] [Related]

  • 4. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
    Inoue S, Oishi M.
    Gene; 2005 Mar 28; 348():123-34. PubMed ID: 15777718
    [Abstract] [Full Text] [Related]

  • 5. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
    Mårtensson UE, Bristulf J, Owman C, Olde B.
    Gene; 2005 Apr 25; 350(1):65-77. PubMed ID: 15792532
    [Abstract] [Full Text] [Related]

  • 6. Gene expression and transcriptional regulation of thrombopoietin.
    Ogami K.
    Stem Cells; 1996 Apr 25; 14 Suppl 1():148-53. PubMed ID: 11012215
    [Abstract] [Full Text] [Related]

  • 7. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
    Tang SH, Yang DH, Huang W, Zhou HK, Lu XH, Ye G.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4171-7. PubMed ID: 16857788
    [Abstract] [Full Text] [Related]

  • 8. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.
    Wang HH, Chiang AN.
    Biochem J; 2004 Jun 01; 380(Pt 2):455-63. PubMed ID: 14984368
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Functional analysis of CpG methylation in the BRCA1 promoter region.
    DiNardo DN, Butcher DT, Robinson DP, Archer TK, Rodenhiser DI.
    Oncogene; 2001 Aug 30; 20(38):5331-40. PubMed ID: 11536045
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH, Wu DC, Tsai CY, Kuo TJ, Yu WC, Chang YS, Chen CL, Chang CF, Chen DS, Chen PJ.
    Clin Cancer Res; 2006 Feb 15; 12(4):1097-108. PubMed ID: 16489062
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J.
    Am J Clin Pathol; 2006 May 15; 125(5):740-6. PubMed ID: 16707376
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [Abstract] [Full Text] [Related]

  • 15. A consensus DNA recognition motif for two KDWK transcription factors identifies flexible-length, CpG-methylation sensitive cognate binding sites in the majority of human promoters.
    Burnett E, Christensen J, Tattersall P.
    J Mol Biol; 2001 Dec 14; 314(5):1029-39. PubMed ID: 11743720
    [Abstract] [Full Text] [Related]

  • 16. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N.
    Cancer Res; 2008 Aug 15; 68(16):6743-51. PubMed ID: 18701499
    [Abstract] [Full Text] [Related]

  • 17. Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta3.
    Archey WB, Sweet MP, Alig GC, Arrick BA.
    Cancer Res; 1999 May 15; 59(10):2292-6. PubMed ID: 10344731
    [Abstract] [Full Text] [Related]

  • 18. A novel protein-DNA interaction involved with the CpG dinucleotide at -30 upstream is linked to the DNA methylation mediated transcription silencing of the MAGE-A1 gene.
    Zhang J, Yu J, Gu J, Gao BM, Zhao YJ, Wang P, Zhang HY, De Zhu J.
    Cell Res; 2004 Aug 15; 14(4):283-94. PubMed ID: 15353125
    [Abstract] [Full Text] [Related]

  • 19. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, Schardt K, Warnecke C, Hellerbrand C, Bosserhoff AK.
    J Pathol; 2009 Aug 15; 218(4):520-9. PubMed ID: 19431154
    [Abstract] [Full Text] [Related]

  • 20. DNA methylation of the human oxytocin receptor gene promoter regulates tissue-specific gene suppression.
    Kusui C, Kimura T, Ogita K, Nakamura H, Matsumura Y, Koyama M, Azuma C, Murata Y.
    Biochem Biophys Res Commun; 2001 Dec 07; 289(3):681-6. PubMed ID: 11726201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.